Cargando…

Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications

Neurodegenerative diseases are incurable, heterogeneous, and age-dependent disorders that challenge modern medicine. A deeper understanding of the pathogenesis underlying neurodegenerative diseases is necessary to solve the unmet need for new diagnostic biomarkers and disease-modifying therapy and r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azevedo, Rita, Jacquemin, Chloé, Villain, Nicolas, Fenaille, François, Lamari, Foudil, Becher, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031030/ https://www.ncbi.nlm.nih.gov/pubmed/35455959 http://dx.doi.org/10.3390/cells11081279

Ejemplares similares

New Antibody-Free Mass Spectrometry-Based Quantification Reveals That C9ORF72 Long Protein Isoform Is Reduced in the Frontal Cortex of Hexanucleotide-Repeat Expansion Carriers
por: Viodé, Arthur, et al.
Publicado: (2018)

The Mediating Roles of Neurobiomarkers in the Relationship Between Education and Late-Life Cognition
por: Amofa-Ho, Priscilla A., et al.
Publicado: (2023)

Multiplex Detection of 24 Staphylococcal Enterotoxins in Culture Supernatant Using Liquid Chromatography Coupled to High-Resolution Mass Spectrometry
por: Lefebvre, Donatien, et al.
Publicado: (2022)

VDACs Post-Translational Modifications Discovery by Mass Spectrometry: Impact on Their Hub Function
por: Pittalà, Maria Gaetana Giovanna, et al.
Publicado: (2021)

Development and Evaluation of an Immuno-MALDI-TOF Mass Spectrometry Approach for Quantification of the Abrin Toxin in Complex Food Matrices
por: Livet, Sandrine, et al.
Publicado: (2021)

A Metabolomic Approach in Search of Neurobiomarkers of Perinatal Asphyxia: A Review of the Current Literature
por: Debuf, Marie Julie, et al.
Publicado: (2021)

PTMselect: optimization of protein modifications discovery by mass spectrometry
por: Perchey, Renaud T., et al.
Publicado: (2019)

Machine learning approach for early onset dementia neurobiomarker using EEG network topology features
por: Rutkowski, Tomasz M., et al.
Publicado: (2023)

The frontal sharp transient in newborns: An endogenous neurobiomarker concomitant to the physiological and critical transitional period around delivery?
por: Routier, Laura, et al.
Publicado: (2022)

Status of Large-scale Analysis of Post-translational Modifications by Mass Spectrometry
por: Olsen, Jesper V., et al.
Publicado: (2013)

Rapid structural characterization of human milk oligosaccharides and distinction of their isomers using trapped ion mobility spectrometry time‐of‐flight mass spectrometry
por: Rathahao‐Paris, Estelle, et al.
Publicado: (2022)

Small Mass but Strong Information: Diagnostic Ions Provide Crucial Clues to Correctly Identify Histone Lysine Modifications
por: Hseiky, Alaa, et al.
Publicado: (2021)

Emulative, coherent, and causal dynamics between large-scale brain networks are neurobiomarkers of Accelerated Cognitive Ageing in epilepsy
por: Bernas, Antoine, et al.
Publicado: (2021)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

Computational refinement of post-translational modifications predicted from tandem mass spectrometry
por: Chung, Clement, et al.
Publicado: (2011)

Investigating capillary electrophoresis‐mass spectrometry for the analysis of common post‐translational modifications
por: Faserl, Klaus, et al.
Publicado: (2018)

Post-translational modifications and glycoprofiling of palivizumab by UHPLC–RPLC/HILIC and mass spectrometry
por: Sran, Kulwinder Singh, et al.
Publicado: (2022)

Urinary Amino Acid Alterations in 3-Year-Old Children with Neurodevelopmental Effects due to Perinatal Dioxin Exposure in Vietnam: A Nested Case-Control Study for Neurobiomarker Discovery
por: Nishijo, Muneko, et al.
Publicado: (2015)

Diagnostic approach in adult-onset neurometabolic diseases
por: Fernández-Eulate, Gorka, et al.
Publicado: (2022)

Global Post-Translational Modification Discovery
por: Li, Qiyao, et al.
Publicado: (2016)

An Improved Top-Down Mass Spectrometry Characterization of Chlamydomonas reinhardtii Histones and Their Post-translational Modifications
por: Rommelfanger, Sarah R., et al.
Publicado: (2021)

Decrypting the potency of anti-cancer therapeutics by using mass spectrometry to quantify post-translational modifications
por: Herbst, Sophie A., et al.
Publicado: (2023)

Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery
por: Ponzini, Erika, et al.
Publicado: (2021)

Recommended Mass Spectrometry-Based Strategies to Identify Ricin-Containing Samples
por: Kalb, Suzanne R., et al.
Publicado: (2015)

Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling
por: Conraux, Laurence, et al.
Publicado: (2013)

Discovery of Post-Translational Modifications in Emiliania huxleyi
por: Duong, Van-An, et al.
Publicado: (2021)

Mass spectrometry analysis of the variants of histone H3 and H4 of soybean and their post-translational modifications
por: Wu, Tao, et al.
Publicado: (2009)

Characterization of Proteoform Post-Translational Modifications by Top-Down and Bottom-Up Mass Spectrometry in Conjunction with Annotations
por: Chen, Wenrong, et al.
Publicado: (2023)

Editorial: Plastid Proteostasis: Relevance of Transcription, Translation, and Post-translational Modifications
por: Alagna, Fiammetta, et al.
Publicado: (2017)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Translating metabolic exchange with imaging mass spectrometry
por: Yang, Yu-Liang, et al.
Publicado: (2009)

Translational Recoding and RNA Modifications
por: Namy, Olivier, et al.
Publicado: (2005)

Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples
por: Noberini, Roberta, et al.
Publicado: (2016)

Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach
por: Noberini, Roberta, et al.
Publicado: (2016)

Mass Spectrometry Targeted Assays as a Tool to Improve Our Understanding of Post-translational Modifications in Pathogenic Bacteria
por: Soares, Nelson C., et al.
Publicado: (2016)

Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)

Discovery of Glycosyltransferases Using Carbohydrate Arrays and Mass Spectrometry
por: Ban, Lan, et al.
Publicado: (2012)

Advances in mass spectrometry-based clinical biomarker discovery
por: Crutchfield, Christopher A., et al.
Publicado: (2016)

Sizing and Discovery of Nanosized Polyoxometalate Clusters by Mass Spectrometry
por: Surman, Andrew J., et al.
Publicado: (2016)

Native Mass Spectrometry in Fragment-Based Drug Discovery
por: Pedro, Liliana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m31t4i4tsapc6ar2dcjo734dao